Skip to main content

Tagged With "Urticaria"

Blog Post

Asthma and Allergy Research Review, April-June 2017

AAFA Community Services ·
The Asthma and Allergy Foundation of America will recap some of the top research on allergies and asthma every quarter. Here is a look at studies reported between April and June 2017. Learn why some children may not respond to asthma treatments, how testosterone may affect asthma and more.
Blog Post

Hives That Won’t Go Away: The Basics of CIU

AAFA Community Services ·
Hives, those annoying itchy red bumps, often occur with an allergic reaction or sometimes a viral infection. Or sometimes, they can be more serious when they happen with a severe allergic reaction called anaphylaxis.
Comment

Re: Hives That Won’t Go Away: The Basics of CIU

NN ·
My spouse is dealing with CIU, with hives on a daily basis. Her allergist landed on CIU and I thought he was just giving up on trying to find the cause, but a ton of independent research has shown that CIU is apparently legit. If anyone with CIU reads this, can you please share any tips on helping with the daily hives? My wife is curious how others with CIU are coping with regards to their job, especially with the hives causing fatigue and frustration, difficult time concentrating, etc.
Comment

Re: Hives That Won’t Go Away: The Basics of CIU

Melissa G ·
Hi NN and welcome to AAFA! I am very sorry to hear that your wife deals with CIU! My oldest daughter also battles CIU. She takes a daily antihistamine to keep it under control. In the beginning, she had to take steroids to help get it under control.
Comment

Re: Hives That Won’t Go Away: The Basics of CIU

Melanie Carver ·
Hi @NN , there are some videos of CIU patient stories available at this link: http://www.ciuandyou.com/videolibrary Hope this helps!
Comment

Re: Asthma and Allergy Research Review, April-June 2017

RSkalak ·
This has some really awesome relevant information for me and the practice I work for!
Blog Post

FDA Accepts Biologics License Application for Xolair® Prefilled Syringe for Self-Administration

AAFA Community Services ·
Novartis today announced that the US Food and Drug Administration (FDA) accepted the company's supplemental Biologics License Application (sBLA) for a new self-administration option for Xolair® (omalizumab) across all approved US indications. If approved, Xolair prefilled syringe would become available for either self-administration by select patients or administration by their caregivers.
Post
×
×
×
×